Pulse Biosciences (PLSE) Competitors $17.17 +0.15 (+0.88%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$16.88 -0.30 (-1.72%) As of 05/1/2025 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PLSE vs. INSP, BLCO, SLNO, IRTC, TMDX, PRCT, NVST, LMAT, LIVN, and ENOVShould you be buying Pulse Biosciences stock or one of its competitors? The main competitors of Pulse Biosciences include Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), Envista (NVST), LeMaitre Vascular (LMAT), LivaNova (LIVN), and Enovis (ENOV). These companies are all part of the "medical equipment" industry. Pulse Biosciences vs. Inspire Medical Systems Bausch + Lomb Soleno Therapeutics iRhythm Technologies TransMedics Group PROCEPT BioRobotics Envista LeMaitre Vascular LivaNova Enovis Pulse Biosciences (NASDAQ:PLSE) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and community ranking. Do analysts prefer PLSE or INSP? Inspire Medical Systems has a consensus target price of $218.90, suggesting a potential upside of 38.39%. Given Inspire Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe Inspire Medical Systems is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.70 Which has stronger earnings & valuation, PLSE or INSP? Inspire Medical Systems has higher revenue and earnings than Pulse Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulse Biosciences$700K1,650.14-$42.21MN/AN/AInspire Medical Systems$802.80M5.86$53.51M$1.7391.43 Does the media prefer PLSE or INSP? In the previous week, Inspire Medical Systems had 10 more articles in the media than Pulse Biosciences. MarketBeat recorded 14 mentions for Inspire Medical Systems and 4 mentions for Pulse Biosciences. Inspire Medical Systems' average media sentiment score of 1.53 beat Pulse Biosciences' score of 0.91 indicating that Inspire Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulse Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspire Medical Systems 12 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is PLSE or INSP more profitable? Inspire Medical Systems has a net margin of 6.67% compared to Pulse Biosciences' net margin of 0.00%. Inspire Medical Systems' return on equity of 8.19% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Pulse BiosciencesN/A -96.89% -74.83% Inspire Medical Systems 6.67%8.19%7.09% Which has more volatility & risk, PLSE or INSP? Pulse Biosciences has a beta of 1.87, suggesting that its stock price is 87% more volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Do insiders and institutionals hold more shares of PLSE or INSP? 76.9% of Pulse Biosciences shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 71.5% of Pulse Biosciences shares are held by company insiders. Comparatively, 4.1% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community favor PLSE or INSP? Pulse Biosciences received 52 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. Likewise, 63.50% of users gave Pulse Biosciences an outperform vote while only 61.71% of users gave Inspire Medical Systems an outperform vote. CompanyUnderperformOutperformPulse BiosciencesOutperform Votes24763.50% Underperform Votes14236.50% Inspire Medical SystemsOutperform Votes19561.71% Underperform Votes12138.29% SummaryInspire Medical Systems beats Pulse Biosciences on 11 of the 16 factors compared between the two stocks. Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLSE vs. The Competition Export to ExcelMetricPulse BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.16B$4.34B$5.49B$7.95BDividend YieldN/A39.94%5.11%4.22%P/E RatioN/A30.6022.6218.58Price / Sales1,650.1455.28397.85103.49Price / CashN/A51.0838.1834.62Price / Book21.206.066.744.25Net Income-$42.21M$68.71M$3.22B$248.18M7 Day Performance-10.90%-0.21%1.59%1.36%1 Month Performance7.72%-2.36%4.09%3.85%1 Year Performance125.92%22.30%15.98%5.37% Pulse Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLSEPulse Biosciences1.0386 of 5 stars$17.17+0.9%N/A+125.9%$1.16B$700,000.000.00140Upcoming EarningsPositive NewsINSPInspire Medical Systems4.8554 of 5 stars$144.74-3.6%$218.90+51.2%-35.2%$4.31B$802.80M83.67760Upcoming EarningsBLCOBausch + Lomb3.702 of 5 stars$12.05-0.1%$18.82+56.2%-15.6%$4.26B$4.79B-13.2412,500Earnings ReportAnalyst ForecastSLNOSoleno Therapeutics4.6413 of 5 stars$68.93-1.5%$99.63+44.5%+57.8%$3.16BN/A-20.7630Upcoming EarningsPositive NewsIRTCiRhythm Technologies0.9603 of 5 stars$98.63-2.3%$119.73+21.4%-2.8%$3.10B$591.84M-27.101,790News CoverageTMDXTransMedics Group3.1845 of 5 stars$87.72-0.6%$122.70+39.9%-23.1%$2.97B$441.54M93.32210Upcoming EarningsAnalyst ForecastPRCTPROCEPT BioRobotics2.7183 of 5 stars$53.43+0.8%$91.43+71.1%-12.8%$2.93B$224.50M-27.40430Earnings ReportAnalyst RevisionHigh Trading VolumeNVSTEnvista3.9412 of 5 stars$14.88-2.0%$19.96+34.2%-17.1%$2.56B$2.51B-2.2912,700Earnings ReportAnalyst ForecastNews CoverageLMATLeMaitre Vascular2.125 of 5 stars$84.72-1.8%$95.25+12.4%+35.1%$1.91B$219.86M46.30490Earnings ReportNews CoveragePositive NewsLIVNLivaNova3.8228 of 5 stars$34.61-2.7%$61.17+76.7%-41.2%$1.88B$1.25B82.402,900Upcoming EarningsNews CoveragePositive NewsENOVEnovis2.7318 of 5 stars$32.25+0.9%$58.50+81.4%-37.7%$1.84B$2.11B-14.736,800Upcoming EarningsPositive News Related Companies and Tools Related Companies INSP Competitors BLCO Competitors SLNO Competitors IRTC Competitors TMDX Competitors PRCT Competitors NVST Competitors LMAT Competitors LIVN Competitors ENOV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PLSE) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
